Pharma manufacturing news in brief
January 17, 2012Manufacturing and Production Biovest International, Corealis, OctoPlus and Tris Pharma, Toray
Toray buys a stake in MicroBiopharm Japan, Corealis wins a manufacturing contract from Kedem Pharma, plus updates from Biovest International, …
Contract research news in brief
January 17, 2012Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma
A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
Otsuka and UCB scale down collaboration
January 16, 2012Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB
Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
AstraZeneca looks for new partners to bolster pipeline
January 16, 2012Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS
AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …
NantWorks to invest $85.5m in former Pfizer plant
January 16, 2012Manufacturing and Production Exubera, Nantworks, Pfizer
A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …
Molecular Profiles starts work on clinical manufacturing facility
January 16, 2012Manufacturing and Production Molecular Profiles
UK contract research and manufacturing services company Molecular Profiles has announced a £9 million investment in manufacturing facilities in the …
Xoma opts out of in-house manufacturing
January 16, 2012Manufacturing and Production Xoma, manufacturing
US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …
Complete Worldwide appoints Andy Turner
January 16, 2012Business Services, Medical Communications, Sales and Marketing Andy Turner, Complete Worldwide
Andy Turner has joined the medical communications firm Complete Worldwide, to head up a new capability they are building in …
Europe wants regulatory reform over PIP implant scandal
January 16, 2012Manufacturing and Production, Sales and Marketing EC, MHRA, PIP implants
The European Commission is seeking regulatory reform for class III medical devices after problems with French-made breast implants. The French …
Covidien appoints Mark Trudeau President of pharmaceuticals segment
January 16, 2012Business Services, Manufacturing and Production, Sales and Marketing Covidien
Covidien has announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the company. …
NICE says yes to Tasigna for resistant disease
January 13, 2012Sales and Marketing BMS, Glivec, NICE, Novartis, Tasigna
NICE is recommending Novartis’ Tasigna for chronic myeloid leukaemia patients that can no longer use Glivec. In final guidance it …
AstraZeneca does data deal
January 13, 2012Sales and Marketing AstraZeneca, IMS Health, data
AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …
Tracy Baker moves to MSI Consultancy
January 13, 2012Medical Communications MSI Consultancy
MSI Consultancy has appointed former Novartis manager Tracy Baker as a new consultant. Tracy has over seven years of sales …
Novartis to cut 2,000 US jobs
January 13, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts
Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …
Pharma unprepared for annus horribilis
January 12, 2012Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma
A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …
Glide Pharma appoints Dr Ian Smith as its new chief executive
January 12, 2012Business Services, Manufacturing and Production, Sales and Marketing
Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …
NICE rejects Sanofi’s Jevtana
January 12, 2012Sales and Marketing Jevtana, NICE, Sanofi, Zytiga
NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …
Merck facility reborn as science park
January 11, 2012Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland
A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
NICE guidance to be enforced, says Lansley
January 11, 2012Sales and Marketing NHS, NICE, PCTs, black lists, prescribing
Local NHS organisations will no longer be allowed to ‘ban’ drugs recommended by NICE, the health secretary has said.England’s primary …
Crisis in the boardroom: 2011’s most dramatic departures
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management
In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
